Balancing Risk Versus Benefit in the Treatment of Waldenström's Macroglobulinemia Patients with Nucleoside Analogue

Balancing Risk Versus Benefit in the Treatment of Waldenström's Macroglobulinemia Patients with Nucleoside Analogue–Based Therapy

Published:2009-03 Issue:1 Volume:9 Page:71-73
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Leleu Xavier,Tamburini Jérome,Roccaro Aldo,Morel Pierre,Soumerai Jacob,Lévy Vincent,Wemeau Mathieu,Balkaran Sandy,Poulain Stephanie,Hunter Zachary R.,Ghobrial Irene M.,Treon Steven P.,Leblond Veronique

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference18 articles.

1. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia;Treon;Blood,2006

2. Waldenstrom Macroglobulinemia;Vijay;Blood,2007

3. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation;Tsimberidou;J Clin Oncol,2006

4. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis;Thornton;Leuk Res,2005

5. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients;Andre;Blood,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waldenstrom Macroglobulinemia;Comprehensive Hematology and Stem Cell Research;2024

2. Ibrutinib plus rituximab for the treatment of adult patients with Waldenström’s macroglobulinemia: a safety evaluation;Expert Opinion on Drug Safety;2021-08-11

3. Cold agglutinin disease revisited: a multinational, observational study of 232 patients;Blood;2020-07-23

4. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia;Frontiers in Immunology;2020-04-07

5. Waldenström’s Macroglobulinemia;Hematologic Malignancies;2018